NASDAQ$BIOX
Bioceres Crop Solutions Corp · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
Bioceres Q3 FY2025: revenue falls 29% to $59.6M with $1.3M net loss
Bioceres Crop Solutions Corp. filed unaudited interim condensed consolidated financial statements for the fiscal third quarter ended March 31, 2025, reporting revenue from contracts with customers of $59.6 million, down from $84.0 million in the prior-year quarter. Operating profit was $0.9 million versus $13.2 million a year ago, and the company posted a net loss attributable to equity holders of $1.3 million compared with net income of $9.3 million in Q3 FY2024, with basic EPS of negative $0.02 versus $0.15. Crop protection remained the largest segment at $42.6 million of revenue, while seed and integrated products contributed $10.2 million. Nine-month revenue was $259.0 million with a $7.5 million net loss attributable to owners.
- Fiscal Q3 revenue from contracts with customers was $59.6 million, down 29% YoY from $84.0 million.
- Operating profit fell to $0.9 million from $13.2 million; net loss attributable to shareholders was $1.3 million.
- Basic EPS was negative $0.02 versus positive $0.15 in the prior-year quarter.
- Crop protection generated $42.6 million of segment revenue; seed and integrated products $10.2 million and crop nutrition $7.8 million.
- Nine-month revenue was $259.0 million with a $7.5 million net loss attributable to equity holders.
Headline financials
Revenue & EPS history
Bioceres · Revenue · Quarterly
$59.6M
Revenue by segment
Bioceres · $60.6M total across 3 segments · Q3 2025
- Crop protection$42.6M—70.4%
- Seed and integrated products$10.2M—16.8%
- Crop nutrition$7.77M—12.8%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
-0.9%
Avg return
Earnings day
-0.0%
Avg return
5 days after
-3.9%
Avg return
30 days after
41%
12 / 29 earnings
Positive
+12.6%
Q3 2023
Best reaction
-14.4%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -5.6% | -20.1% | -20.7% | |
| Q2 2026 | -9.2% | -12.8% | -16.0% | |
| Q3 2025 | -5.2% | -0.4% | -2.4% | |
| Q4 2024 | -14.4% | -15.2% | -26.2% | |
| Q3 2024 | -7.0% | -10.8% | -16.2% | |
| Q2 2024 | +4.0% | +3.1% | +1.5% | |
| Q1 2024 | +6.7% | +13.6% | +28.0% | |
| Q4 2023 | -2.3% | -0.4% | -4.1% | |
| Q3 2023 | +12.6% | +20.3% | +22.5% | |
| Q2 2023 | -8.4% | -2.4% | -6.8% | |
| Q1 2023 | +5.5% | +1.9% | -12.7% | |
| Q4 2022 | -2.9% | -2.9% | -10.3% | |
| Q3 2022 | +5.4% | +12.8% | +9.7% | |
| Q2 2022 | +1.8% | +1.4% | +19.1% | |
| Q1 2022 | +8.2% | +15.9% | +9.0% | |
| Q4 2021 | -6.5% | -8.2% | -2.2% | |
| Q3 2021 | +3.0% | +5.6% | -5.3% | |
| Q2 2021 | -1.9% | -1.7% | -7.5% | |
| Q1 2021 | -0.2% | -0.7% | -7.2% | |
| Q4 2020 | +4.8% | +7.0% | +17.9% | |
| Q3 2020 | -6.6% | -1.9% | -4.0% | |
| Q2 2020 | +4.7% | +13.5% | -12.5% | |
| Q1 2020 | -5.5% | -0.7% | -7.7% | |
| Q4 2019 | +0.0% | -7.4% | -6.6% | |
| Q3 2019 | -8.7% | -11.1% | -7.2% | |
| Q2 2019 | +0.2% | +0.2% | -47.4% | |
| Q1 2019 | +0.0% | +0.0% | +2.6% | |
| Q4 2018 | +0.2% | +0.0% | +0.2% | |
| Q3 2018 | +0.0% | +0.7% | +0.5% | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro